Everything below concerns AOD-9604. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Communist ideologies and ideas have acquired a new meaning since the Russian Revolution, as they became equivalent to the ideas of Marxism–Leninism, namely the interpretation of Marxism by Vladimir Lenin and his successors. Endorsing the final objective, namely the creation of a community-owning means of production and providing each of its participants with consumption "according to their needs", Marxism–Leninism puts forward the recognition of the class struggle as a dominating principle of a social change and development. In addition, workers (the proletariat) were to carry out the mission of reconstruction of the society. Conducting a socialist revolution led by what its proponents termed the "vanguard of the proletariat", defined as the communist party organised hierarchically through democratic centralism, was hailed to be a historical necessity by Marxist–Leninists. Moreover, the introduction of the proletarian dictatorship was advocated and classes deemed hostile were to be repressed. In the 1920s, it was first defined and formulated by Joseph Stalin based on his understanding of orthodox Marxism and Leninism. In 1934, Karl Radek suggested the formulation Marxism–Leninism–Stalinism in an article in Pravda to stress the importance of Stalin's leadership to the Marxist–Leninist ideology. Radek's suggestion failed to catch on, as Stalin as well as CPSU's ideologists preferred to continue the usage of Marxism–Leninism.
Michael Hurley (born 1 June 1990) is a former professional Australian rules footballer who played for the Essendon Football Club in the Australian Football League (AFL). He attended Viewbank College and was recruited by the Essendon Football Club with the fifth overall selection in the 2008 national draft.
== Safety and toxicity == Excess pre‑formed vitamin A from supplements or fortified foods can cause hypervitaminosis A, characterized acutely by nausea and raised intracranial pressure and chronically by liver injury and teratogenicity. Retinyl acetate shares these dose‑dependent toxicities because it is quantitatively hydrolyzed to retinol. Phototoxicity and photo‑isomerization are significantly lower than for unesterified retinol but can occur in formulations lacking UV stabilizers.
Sources: en.wikipedia.org
Subsequent follow-up recessions in 2010–2013 were confined to Belize, El Salvador, Paraguay, Jamaica, Japan, Taiwan, New Zealand and 24 out of 50 European countries (including Greece). As of October 2014, only five out of the 71 countries with available quarterly data (Cyprus, Italy, Croatia, Belize and El Salvador), were still in ongoing recessions. The many follow-up recessions hitting the European countries, are commonly referred to as being direct repercussions of the European debt crisis.
== Structure == Sericin is composed of 18 different amino acids, of which 32% is serine. The secondary structure is usually a random coil, but it can also be easily converted into a β-sheet conformation, via repeated moisture absorption and mechanical stretching. The serine hydrogen bonds give its glue-like quality. The genes encoding sericin proteins have been sequenced. Its C-terminal part contains many serine-rich repeats. Using gamma ray examination, it was determined that sericin fibers are composed typically of three layers, all with fibers running in different patterns of directionality. The innermost layer, typically is composed of longitudinally running fibers, the middle layer is composed of cross fiber directional patterned fibers, and the outer layer consists of fiber directional fibers. The overall structure can also vary based on temperature, whereas the lower the temperature, there were typically more β-sheet conformations than random amorphous coils. There are also three different types of sericin, which make up the layers found on top of the fibroin. Sericin A, which is insoluble in water, is the outermost layer, and contains approximately 17% nitrogen, along with amino acids such as serine, threonine, aspartic acid, and glycine. Sericin B, composed the middle layer and is nearly the same as sericin A, but also contains tryptophan. Sericin C is the innermost layer, the layer that comes closest to and is adjacent to fibroin. Also insoluble in water, sericin C can be separated from the fibroin via the addition of a hot, weak acid.
L.L. Bartlett (2010). "Cold Case". A Jeff Resnick Mystery. ASIN B003I84LYW. Polaris Press. This short story inspired the fourth Jeff Resnick book, Bound by Suggestion. Philip Gourevitch (2002). A Cold Case. Macmillan. ISBN 978-0312420024. True crime. Julia Platt Leonard (2012). Cold Case. Aladdin. ISBN 978-1442420090. A children's book/mystery. Nichelle Walker (2012). Cold Case Love. NWHoodTales Publishing. ISBN 978-0979402838. An urban novel. Richard H. Walton, ed. (2006). Cold Case Homicides: Practical Investigative Techniques. CRC Press. ISBN 084932209X. An education and reference book. Stephen White (2001). Cold Case. Alan Gregory. ISBN 978-0525945260. Kate Wilhelm (2009). Cold Case. Barbara Holloway Novels. ISBN 978-0778326656.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.